BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,631 | +11.7% | 371 | +40.5% | 0.00% | – |
| Q2 2023 | $16,684 | +34.8% | 264 | -4.0% | 0.00% | – |
| Q1 2023 | $12,373 | -0.9% | 275 | -3.5% | 0.00% | – |
| Q4 2022 | $12,486 | +13.5% | 285 | +63.8% | 0.00% | – |
| Q3 2022 | $11,000 | +22.2% | 174 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 174 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -35.3% | 174 | +7.4% | 0.00% | – |
| Q4 2021 | $17,000 | -34.6% | 162 | -35.5% | 0.00% | – |
| Q3 2021 | $26,000 | -10.3% | 251 | -23.7% | 0.00% | – |
| Q2 2021 | $29,000 | +38.1% | 329 | +51.6% | 0.00% | – |
| Q1 2021 | $21,000 | -4.5% | 217 | +11.9% | 0.00% | – |
| Q4 2020 | $22,000 | -12.0% | 194 | -27.9% | 0.00% | – |
| Q3 2020 | $25,000 | +25.0% | 269 | +6.7% | 0.00% | – |
| Q2 2020 | $20,000 | – | 252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |